Evidence map›Paper›PMID 21445287›Full record

Trial reportPloS one2011

Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial.

Andrew J Goldson, Susan J Fairweather-Tait, Charlotte N Armah, Yongping Bao, Martin R Broadley, Jack R Dainty, Caroline Furniss, David J Hart, Birgit Teucher, Rachel Hurst

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00279812 nacompletednot on this map

Selenium and Immune Function

TypeinterventionalSponsorQuadram Institute BioscienceRan2005 to 2008Enrolled133ConditionsHealthyArms50ug selenium enriched yeast, 100ug selenium enriched yeast, 200ug selenium enriched yeast, Control onion, Enriched onion
NCT04798677 nacompletednot on this mapstarted 2020, after this paper: background citation

Efficacy and Tolerability of a Nutritional Supplementation With ABBC-1, a Symbiotic Combination of Beta-glucans and Selenium and Zinc Enriched Probiotics, in Volunteers Receiving the Influenza or the Covid-19 Vaccines

TypeinterventionalSponsorAB BiotekRan2020 to 2021Enrolled72ConditionsImmunity, Vaccine Reaction, Influenza, Covid19ArmsABBC1 Immunoessential, Placebo
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Selenium-enrichedFrontiers in fungal biology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Selenium can regulate the differentiation and immune function of human dendritic cells.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Association of Gpx1 fluctuation in cell cycle progression.In vitro cellular & developmental biology. Animal · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Andrew J GoldsonInstitute of Food Research, Norwich Research Park, Norwich, United Kingdom.
Susan J Fairweather-Tait
Charlotte N Armah
Yongping Bao
Martin R Broadley
Jack R Dainty
Caroline Furniss
David J Hart
Birgit Teucher
Rachel Hurst
Quadram Institute · GBUniversity of East Anglia · GBNorwich Research Park · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe uncertainty surrounding dietary requirements for selenium (Se) is partly due to limitations in biomarkers of Se status that are related to health outcomes. In this study we determined the effect of different doses and forms of Se on gene expression of selenoprotein S (SEPS1), selenoprotein W (SEPW1) and selenoprotein R (SEPR), and responses to an immune function challenge, influenza vaccine, were measured in order to identify functional markers of Se status. METHODS AND

findingsA 12 week human dietary intervention study was undertaken in 119 volunteers who received placebo, 50, 100 or 200 µg/day Se-enriched yeast (Se-yeast) or meals containing unenriched or Se-enriched onions (50 µg/day). Gene expression was quantified in RNA samples extracted from human peripheral blood mononuclear cells (PBMC's) using quantitative RT-PCR. There was a significant increase in SEPW1 mRNA in the Se-enriched onion group (50 µg/day) compared with the unenriched onion group. SEPR and SEPW1 did not change significantly over the duration of the supplementation period in the control or Se-yeast groups, except at week 10 when SEPW1 mRNA levels were significantly lower in the 200 µg/day Se-yeast group compared to the placebo group. Levels of SEPS1 mRNA increased significantly 7 days after the influenza vaccine challenge, the magnitude of the increase in SEPS1 gene expression was dose-dependent, with a significantly greater response with higher Se supplementation.

conclusionsThis novel finding provides preliminary evidence for a role of SEPS1 in the immune response, and further supports the relationship between Se status and immune function.

trial registrationClinicalTrials.gov [NCT00279812].

Indexed as

Dietary SupplementsBlood PlateletsDouble-Blind MethodGene Expression RegulationGlutathione PeroxidaseHumansInfluenza VaccinesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSeleniumSelenoproteinsGlutathione PeroxidaseInfluenza VaccinesRNA, MessengerSeleniumSelenoproteins

Identifiers

PMID21445287
PMCPMC3061857
OpenAlexW1993098161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.